Ghost Tree Capital as of Sept. 30, 2024
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 52 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 9.0 | $30M | 300k | 98.80 | |
| Biohaven Call | 5.3 | $17M | 349k | 49.97 | |
| Sarepta Therapeutics (SRPT) | 4.5 | $15M | 120k | 124.89 | |
| Novo-nordisk A S Adr (NVO) | 4.0 | $13M | 110k | 119.07 | |
| Blueprint Medicines (BPMC) | 3.9 | $13M | 140k | 92.50 | |
| Axsome Therapeutics (AXSM) | 3.7 | $12M | 135k | 89.87 | |
| Tarsus Pharmaceuticals (TARS) | 3.5 | $12M | 350k | 32.89 | |
| Perspective Therapeutics Com New (CATX) | 3.0 | $10M | 750k | 13.35 | |
| Cg Oncology (CGON) | 2.8 | $9.4M | 250k | 37.73 | |
| Roivant Sciences SHS (ROIV) | 2.8 | $9.2M | 800k | 11.54 | |
| Vaxcyte (PCVX) | 2.8 | $9.1M | 80k | 114.27 | |
| Insmed Com Par $.01 (INSM) | 2.8 | $9.1M | 125k | 73.00 | |
| Viking Therapeutics (VKTX) | 2.7 | $8.9M | 140k | 63.31 | |
| Syndax Pharmaceuticals (SNDX) | 2.6 | $8.7M | 450k | 19.25 | |
| Janux Therapeutics (JANX) | 2.6 | $8.6M | 190k | 45.43 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 2.4 | $7.8M | 380k | 20.63 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.4 | $7.8M | 53k | 149.31 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.3 | $7.7M | 150k | 51.10 | |
| Soleno Therapeutics (SLNO) | 2.3 | $7.6M | 150k | 50.49 | |
| Tg Therapeutics (TGTX) | 2.2 | $7.3M | 310k | 23.39 | |
| Rezolute Com New (RZLT) | 2.2 | $7.2M | 1.5M | 4.85 | |
| Phathom Pharmaceuticals (PHAT) | 2.0 | $6.8M | 375k | 18.08 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.0 | $6.5M | 128k | 50.42 | |
| Olema Pharmaceuticals (OLMA) | 1.9 | $6.4M | 535k | 11.94 | |
| Immunovant (IMVT) | 1.9 | $6.1M | 215k | 28.51 | |
| Edgewise Therapeutics (EWTX) | 1.6 | $5.2M | 195k | 26.69 | |
| Replimune Group (REPL) | 1.5 | $4.9M | 450k | 10.96 | |
| Bridgebio Pharma (BBIO) | 1.3 | $4.5M | 175k | 25.46 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.3 | $4.3M | 2.2M | 2.01 | |
| Rhythm Pharmaceuticals (RYTM) | 1.2 | $4.1M | 79k | 52.39 | |
| Annexon (ANNX) | 1.2 | $3.8M | 650k | 5.92 | |
| Korro Bio (KRRO) | 1.1 | $3.7M | 110k | 33.42 | |
| Dyne Therapeutics (DYN) | 1.1 | $3.6M | 100k | 35.92 | |
| Arvinas Ord (ARVN) | 1.1 | $3.6M | 145k | 24.63 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.9 | $3.1M | 300k | 10.45 | |
| Nuvation Bio Com Cl A (NUVB) | 0.9 | $3.1M | 1.4M | 2.29 | |
| Savara (SVRA) | 0.9 | $3.1M | 725k | 4.24 | |
| Tenaya Therapeutics (TNYA) | 0.9 | $2.9M | 1.5M | 1.93 | |
| Regenxbio Inc equity us cm (RGNX) | 0.8 | $2.8M | 265k | 10.49 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $2.6M | 500k | 5.28 | |
| Absci Corp (ABSI) | 0.6 | $2.1M | 550k | 3.82 | |
| Neurogene (NGNE) | 0.6 | $2.1M | 50k | 41.96 | |
| Capricor Therapeutics Com New (CAPR) | 0.6 | $1.9M | 125k | 15.21 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $1.9M | 65k | 28.84 | |
| Summit Therapeutics (SMMT) | 0.6 | $1.9M | 85k | 21.90 | |
| Spyre Therapeutics Com New (SYRE) | 0.5 | $1.8M | 60k | 29.41 | |
| Miragen Therapeutics (VRDN) | 0.5 | $1.7M | 75k | 22.75 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.5 | $1.6M | 888k | 1.82 | |
| Atyr Pharma Com New (ATYR) | 0.4 | $1.4M | 800k | 1.76 | |
| Larimar Therapeutics (LRMR) | 0.4 | $1.3M | 200k | 6.55 | |
| Engene Holdings (ENGN) | 0.3 | $1.1M | 161k | 6.60 | |
| Amylyx Pharmaceuticals (AMLX) | 0.3 | $1.1M | 325k | 3.24 |
